Atif Ali Hashmi

7PUBLICATIONS
35CO-AUTHORS
Clinical midwiferyMolecular targetsMedical mycologyCancer diagnosisPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Nov 10, 2025
Trastuzumab Deruxtecan Resistance via Loss of HER2 Expression and Binding.

Wanyi Chen, Avantika Gupta, Nicholas Mai

|Oct 09, 2025
Programmed Death Ligand 1 (PDL1) Expression in Neoadjuvant Triple-Negative Breast Cancer: Association With Chemotherapy Response and Residual Cancer Burden.

Atif Ali Hashmi, Noreen Wahid, Ghazala Mudassir

|Apr 29, 2025
Clinicopathological features of microinvasive lobular carcinoma.

Rachel Han, Atif A Hashmi, Hannah Y Wen

|Feb 26, 2025
Predictive Value of Excision Repair Cross Complementation Group 1 (ERCC1) by Immunohistochemistry for Determining Neoadjuvant Chemotherapy Response in Triple-Negative Breast Cancers.

Atif Ali Hashmi, Yumna Ajaz, Muhsana Sajjad

|Sep 05, 2024
Risk Factors of Oral Squamous Cell Carcinoma with Special Emphasis on Areca Nut Usage and Its Association with Clinicopathological Parameters and Recurrence.

Atif Ali Hashmi, Ghazala Mudassir, Khushbakht Rashid

|Apr 11, 2024
Significance of Estrogen/Progesterone Receptor Expression in Metaplastic Breast Carcinoma.

Atif Ali Hashmi, Bakhtawar Allauddin Mallick, Khushbakht Rashid

Pageof 2

Frequent Collaborators

4 joint publications

Muhammad Irfan

3 joint publications

Fazail Zia

3 joint publications

Umair Arshad Malik

2 joint publications

Shamail Zia